Board of Directors

• Board-certified MD (Anesthesiology and Intensive Care) and DDS, Karolinska Institutet
• Associate Professor and PhD in Physiology, Karolinska Institutet

• Executive VP Global Medicines Development, Global Head Clinical Development, Global Therapy Area Head, and CEO, AstraZeneca AB Sweden.
• Director and Chairman of the board, Karolinska university Hospital

• Chairman/Non-Executive Board member of AnaMar AB, Alligator Bioscience AB, Elypta AB, Flerie Invest AB, Mereo BioPharma Group Plc, and Xspray Pharma AB

• Professor of Physiology at Stockholm University
• 25 years of experience in pharmacology and physiology
• 60+ scientific publications
• 20+ patent applications
• Entrepreneur and founder of several companies

• MD and PhD in Cell and Molecular Biology, Lund University

• Medical Director, Swedish Orphan Biovitrum
• Medical Advisor, Sanofi
• Financial analyst, Aragon Securities,

• CEO and Founder of Cormorant Pharmaceuticals

• CEO of Sixera Pharma
• Board member of Amarna Therapeutics BV, Cavis Technologies AB and Xintela AB

• M.Sc. in Business and Administration with a double major in Finance and Information Management, Stockholm School of Economics

• Founder and CEO of Exeger
• Senior adviser to Royal Institute of Technology, Applied Finance Institute
• Member of Sting (Stockholm Innovation & Growth) advisory board.

• Entrepreneur and investor with investments from real estate development, nanotechnology, IT, and life science to pharmaceutical companies
• Member of several boards of directors

• More than 25 years of experience as an entrepreneur and investor from various industries
• Founder/co-founder of several companies in real estate development, brokerage, med-tech and life science
• CEO and member and chairman of the board of several companies

• PhD in Dentistry Karolinska Institutet

• Senior Advisor, Flerie Invest AB
• Executive Vice President, Global Technologies, Recipharm AB
• Director Nordic Region, Country Manager Sweden, Meda AB

• Board member of Symcel Sweden AB, Xspray Pharma AB, Buzzard Pharmaceuticals AB, Pharmacolog AB, KAHR Medical Ltd, EpiEndo Pharmaceuticals ehf

• M.D., Weil Cornell Medical College
• Advanced Management Program, Harvard Business School

• Founder & Principal, 1.618 Consulting LLC
• Chief Medical Advisor, Banner Health Science
• Board of Directors, rTerra
• CEO, Arno Therapeutic
• President Global R&D, Wyeth Consumer Healthcare
• Executive Director of International Regulatory, Merck
• Executive Director Clinical Research, Merck Research Laboratories
• Gastroenterologist in Clinical Practice
• Resident & Research Fellow in Gastroenterology, Stanford U Hospital

• Scientific and Regulatory Advisory Board – 3D Communications

Education

• B.S and M.S. in Control and Instrumentation Engineering from Seoul National University

• Managing Director of Investments at Korea Investment Partners (KIP)
• Head of Korea Investment Partners’ US office based in Silicon Valley
• 18 years of industrial experiences in diverse area and companies in IT including Samsung Electronics, Dasan networks, as well as successful venture startups including Neomtel and Polidigm

• Board member of Prokarium Ltd, Enlivex, Geneos Therepeutics, and PDC*line Pharma